14 Sep 2017 | 10:50 am | 1 min. read
International law firm Pinsent Masons has advised University Hospitals Birmingham NHS Foundation Trust (UHB), one of the pre-eminent NHS trusts both nationally and internationally, on its successful bid to obtain Competition and Markets Authority approval for a merger with Heart of England NHS Foundation Trust.
The merger involves the two largest NHS acute trusts in Birmingham, requiring a careful assessment of the substantial benefits which the merger would realise for the surrounding population against any perceived reduction in choice for patients.
Pinsent Masons supported the UHB Executive Team, along with a team of specialist economic advisors at NERA Economic Consulting, to deliver effective submissions to the CMA and secure the support of key stakeholders, particularly NHS Improvement.
Kate Collyer, Deputy Chief Economic Adviser at the CMA and the decision maker in the case, said:
“This is the first time the CMA has cleared an NHS hospital merger on the basis of patient benefits at phase 1 and [this] reflects the quality of the benefits case put forward....The hospitals involved presented clear evidence and a well-reasoned case."
The Pinsent Masons team was led by EU and Competition partner Giles Warrington with support from Associate Tim Riisager. Legal Director Graham Fyfe is continuing to advise UHB on the structural aspects of the merger.
“By avoiding a detailed Phase 2 review, as has been required in other NHS Trust mergers, the parties are in a position to finalise the merger and deliver further, major improvements for their patients sooner. This decision also could have potentially positive implications for the wider NHS as other acute trusts consider their merger options.”
Giles Warrington has previously represented Hanson Quarry Products Europe on the CMA's market investigation into the supply of aggregates and cement, while the wider Pinsent Masons EU and Competition team has acted as lead external counsel to E.ON in relation to the CMA's market investigation of the energy market, and to Clydesdale Bank in relation to the retail banking market investigation. In January the firm re-appointed Alan Davis from Jones Day to leads its EU and Competition team.
Multinational law firm Pinsent Masons has launched a new working-from home audit tool to help financial services organisations understand the hidden litigation and regulatory risks associated with staff increasingly working from home on a more permanent basis.
Multinational law firm Pinsent Masons is advising Seraphine Group plc, an international digitally-led maternity and nursing wear, on its IPO and premium listing on the main market of the London Stock Exchange.
Multinational law firm Pinsent Masons has today signed a memorandum of understanding (MOU) with Nepal International ADR Center (NIAC), commencing an important collaborative relationship seeking to enhance NIAC’s international arbitration capabilities.
Multinational law firm Pinsent Masons advised GNA Biosolutions GmbH on IP and commercial aspects of its rapid PCR Covid-19 test.
Pinsent Masons has advised Unbound on its investment in etone Motion Analysis GmbH (VAHA), a manufacturer of smart digital mirrors.
The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on